These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20371355)

  • 21. Electrochemical surface plasmon resonance: basic formalism and experimental validation.
    Wang S; Huang X; Shan X; Foley KJ; Tao N
    Anal Chem; 2010 Feb; 82(3):935-41. PubMed ID: 20047281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fragment screening using surface plasmon resonance optical biosensor technology].
    Miura T
    Yakugaku Zasshi; 2010 Mar; 130(3):341-8. PubMed ID: 20190519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SPR for molecular interaction analysis: a review of emerging application areas.
    Karlsson R
    J Mol Recognit; 2004; 17(3):151-61. PubMed ID: 15137023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-throughput affinity ranking of antibodies using surface plasmon resonance microarrays.
    Wassaf D; Kuang G; Kopacz K; Wu QL; Nguyen Q; Toews M; Cosic J; Jacques J; Wiltshire S; Lambert J; Pazmany CC; Hogan S; Ladner RC; Nixon AE; Sexton DJ
    Anal Biochem; 2006 Apr; 351(2):241-53. PubMed ID: 16510109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fragment-based screening by biochemical assays: Systematic feasibility studies with trypsin and MMP12.
    Boettcher A; Ruedisser S; Erbel P; Vinzenz D; Schiering N; Hassiepen U; Rigollier P; Mayr LM; Woelcke J
    J Biomol Screen; 2010 Oct; 15(9):1029-41. PubMed ID: 20855559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SPR-based fragment screening: advantages and applications.
    Neumann T; Junker HD; Schmidt K; Sekul R
    Curr Top Med Chem; 2007; 7(16):1630-42. PubMed ID: 17979772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection criteria for drug-like compounds.
    Muegge I
    Med Res Rev; 2003 May; 23(3):302-21. PubMed ID: 12647312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Affinity constants for small molecules from SPR competition experiments.
    de Mol NJ
    Methods Mol Biol; 2010; 627():101-11. PubMed ID: 20217616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid and label-free bacteria detection by surface plasmon resonance (SPR) biosensors.
    Dudak FC; Boyaci IH
    Biotechnol J; 2009 Jul; 4(7):1003-11. PubMed ID: 19288516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SPR biosensor as a tool for screening prion protein binders as potential antiprion leads.
    Chen B
    Methods Mol Biol; 2010; 627():147-55. PubMed ID: 20217619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fragment-based lead discovery and design.
    Joseph-McCarthy D; Campbell AJ; Kern G; Moustakas D
    J Chem Inf Model; 2014 Mar; 54(3):693-704. PubMed ID: 24490951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomolecular interactions by Surface Plasmon Resonance technology.
    Torreri P; Ceccarini M; Macioce P; Petrucci TC
    Ann Ist Super Sanita; 2005; 41(4):437-41. PubMed ID: 16569911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surface plasmon resonance biosensor for biomolecular interaction analysis based on spatial modulation phase detection.
    Ding X; Liu F; Yu X
    Methods Mol Biol; 2009; 503():21-35. PubMed ID: 19151934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surface plasmon resonance biosensing.
    Piliarik M; Vaisocherová H; Homola J
    Methods Mol Biol; 2009; 503():65-88. PubMed ID: 19151937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time-resolved fluorescence resonance energy transfer and surface plasmon resonance-based assays for retinoid and transthyretin binding to retinol-binding protein 4.
    Sharif O; Hu H; Klock H; Hampton EN; Nigoghossian E; Knuth MW; Matzen J; Anderson P; Trager R; Uno T; Glynne RJ; Azarian SM; Caldwell JS; Brinker A
    Anal Biochem; 2009 Sep; 392(2):162-8. PubMed ID: 19482004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of chromogenic reagents in surface plasmon resonance (SPR).
    Mavri J; Raspor P; Franko M
    Biosens Bioelectron; 2007 Jan; 22(6):1163-7. PubMed ID: 16930983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing the hit-to-lead process using SPR analysis.
    Löfås S
    Assay Drug Dev Technol; 2004 Aug; 2(4):407-15. PubMed ID: 15357922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Src homology-2 domain binding assays by scintillation proximity and surface plasmon resonance.
    Mandine E; Gofflo D; Jean-Baptiste V; Sarubbi E; Touyer G; Deprez P; Lesuisse D
    J Mol Recognit; 2001; 14(4):254-60. PubMed ID: 11500972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetic analysis and fragment screening with Fujifilm AP-3000.
    Rich RL; Myszka DG
    Anal Biochem; 2010 Jul; 402(2):170-8. PubMed ID: 20371220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-impedance-based label-free technology for the identification of new drugs.
    Lundstrom K
    Expert Opin Drug Discov; 2017 Apr; 12(4):335-343. PubMed ID: 28276704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.